Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences

Table 3

Expression of NeuGcGM3 in relation to clinicopathological characteristics in NSCLC.

Clinicopathological features ()	NeuGcGM3 expression		value
	(-score)
	Low	High
Gender
Female	15	16	0.469
Masculine	23	36
Age (years)
<60	26	32	0.365
≥60	12	20
Tumor size (cm)
<3	12	15	0.832
≥3	26	37
Lymph node metastasis
Yes	9	21	0.403
No	29	31
Other sites metastasis
Yes	3	4	0.669
No	35	48
Stage
I-II	35	45	0.562
III-IV	3	7
Disease recurrence
Yes	11	21	0.632
No	27	31
Histological type
Epidermoid carcinoma	8	18	0.008
Adenocarcinoma	15	28
Others	15	6
Grade of differentiation
Well/moderate	22	33	0.905
Poor	16	19

Fisher exact test; Chi-square test.